Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM)
Abstract
Caring about the clinical impact of laboratory results, beyond their technical performance, has been part of the clinical microbiologist's mission since the very origins of the discipline. The term diagnostic stewardship is more recent, emerging from a renewed need created by powerful new diagnostic technologies: as testing becomes faster, more sensitive and more widely used, results grow harder to interpret and easier to misuse. A result reported without interpretation is not neutral, and diagnostic misuse readily translates into inappropriate antibiotic use, making the laboratory an unrecognised driver of antibiotic prescription, while microbiologists have ever less time for clinical engagement. Diagnostic stewardship is thus a universal challenge, with a scope that extends well beyond antimicrobial use to virology, mycology, outbreak management, screening programmes and infection prevention and control. In this position statement, the French Society for Microbiology argues that diagnostic stewardship is a core mission of clinical microbiologists and calls for the microbiologist to be repositioned as an active clinical actor rather than a passive provider of results. We discuss how this role varies across healthcare systems, notably between the United States and Europe. We propose concrete actions at the individual, laboratory and national levels. These actions are generalizable to other settings, provided they are adapted to the local context. We argue that the main obstacle is structural: when laboratory activity is measured and funded by test volume, the interpretive work that turns results into sound medical decisions goes unrewarded. While we focus on hospital practice, these principles apply equally to community settings. Recognizing and supporting this distinctive clinical role of microbiologists is now essential.
Related
- The rise of diagnostic identities in society
- Expert Consensus-Based Clinical Practice Guidelines for Care and Weaning Procedures in Tracheostomized ICU Patients after Invasive Mechanical Ventilation: A Joint Statement by the Intensive Care Physiotherapy Society (SKR) and the French Intensive Care Society (SRLF)
- Effectiveness of Clinical Pathway Pop-Up Window Insertion in Computer-Based Prescription System for Antibiotic Stewardship in Acute Diarrhea.
- Artificial intelligence and antimicrobial stewardship: From clinical decision support to public health action-On behalf of APUA
- Impact of Pharmacist-Involved Antimicrobial Stewardship Interventions on Clinical and Process Outcomes in Multidrug-Resistant Organism Infections: A Systematic Review and Meta-Analysis.
BibTeX
@article{mizrahi2026diagnostic,
title = {{Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM)}},
author = {Assaf Mizrahi and Christophe Burucoa and Jérôme Le Goff and Alban Le Monnier and Sonia Burrel and Marlène Amara and Sandrine Boisset and David Boutolleau and Pierre Cassier and Sophie Jarraud and Marine Jourdain and Marie Kempf and Brigitte Lamy and Mathieu Maillard and Guillaume Miltgen and Sabine Pereyre},
journal = {Clinical Microbiology and Infection},
year = {2026},
month = oct,
doi = {10.1016/j.cmi.2026.09.013},
url = {https://hal.science/hal-05782784v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM)
AU - Assaf Mizrahi
AU - Christophe Burucoa
AU - Jérôme Le Goff
AU - Alban Le Monnier
AU - Sonia Burrel
AU - Marlène Amara
AU - Sandrine Boisset
AU - David Boutolleau
AU - Pierre Cassier
AU - Sophie Jarraud
AU - Marine Jourdain
AU - Marie Kempf
AU - Brigitte Lamy
AU - Mathieu Maillard
AU - Guillaume Miltgen
AU - Sabine Pereyre
PY - 2026
DA - 2026/10/07
JO - Clinical Microbiology and Infection
DO - 10.1016/j.cmi.2026.09.013
UR - https://hal.science/hal-05782784v1
AB - Caring about the clinical impact of laboratory results, beyond their technical performance, has been part of the clinical microbiologist's mission since the very origins of the discipline. The term diagnostic stewardship is more recent, emerging from a renewed need created by powerful new diagnostic technologies: as testing becomes faster, more sensitive and more widely used, results grow harder to interpret and easier to misuse. A result reported without interpretation is not neutral, and diagnostic misuse readily translates into inappropriate antibiotic use, making the laboratory an unrecognised driver of antibiotic prescription, while microbiologists have ever less time for clinical engagement. Diagnostic stewardship is thus a universal challenge, with a scope that extends well beyond antimicrobial use to virology, mycology, outbreak management, screening programmes and infection prevention and control. In this position statement, the French Society for Microbiology argues that diagnostic stewardship is a core mission of clinical microbiologists and calls for the microbiologist to be repositioned as an active clinical actor rather than a passive provider of results. We discuss how this role varies across healthcare systems, notably between the United States and Europe. We propose concrete actions at the individual, laboratory and national levels. These actions are generalizable to other settings, provided they are adapted to the local context. We argue that the main obstacle is structural: when laboratory activity is measured and funded by test volume, the interpretive work that turns results into sound medical decisions goes unrewarded. While we focus on hospital practice, these principles apply equally to community settings. Recognizing and supporting this distinctive clinical role of microbiologists is now essential.
SN - 1198-743X
SN - 1469-0691
ER -